Bluejay Diagnostics (BJDX) Receivables - Other (2022 - 2025)

Bluejay Diagnostics has disclosed Receivables - Other across 4 years of filings, most recently posting $6873.0 for Q1 2025.

• Receivables - Other for Q1 2025 came in at $6873.0, down 90.66% year-over-year; the trailing twelve-month figure through Mar 2025 was $6873.0 (down 90.66% YoY), and the FY2024 annual result was $14564.0, down 64.71% from the prior year.
• Receivables - Other came in at $6873.0 for Q1 2025 at Bluejay Diagnostics, down from $14564.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $73591.0 in Q1 2024 to a low of $6873.0 in Q1 2025.
• The 4-year median for Receivables - Other is $25170.0 (2022), against an average of $29098.8.
• Across the five-year window, Receivables - Other surged 109.16% in 2023 and sank 90.66% in 2025, its largest moves.
• Bluejay Diagnostics' Receivables - Other stood at $19731.0 in 2022, then surged by 109.16% to $41269.0 in 2023, then plunged by 64.71% to $14564.0 in 2024, then plunged by 52.81% to $6873.0 in 2025.
• The last three Receivables - Other figures came in at $6873.0 (Q1 2025), $14564.0 (Q4 2024), and $8315.0 (Q3 2024), per Business Quant data.